| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/25/2001 | WO2001036650A2 An oncolytic adenovirus |
| 05/25/2001 | WO2001036646A1 Inhibiting gene expression with dsrna |
| 05/25/2001 | WO2001036640A2 Human fgf-21 gene and gene expression products |
| 05/25/2001 | WO2001036630A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 05/25/2001 | WO2001036629A1 Transfer compounds, the production and the use thereof |
| 05/25/2001 | WO2001036605A2 2786, a human aminopeptidase |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036599A1 Microparticle-based transfection and activation of dendritic cells |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036483A1 Use of the insulin-like-growth factor i isoform mgf for the treatment of neurological disorders |
| 05/25/2001 | WO2001036476A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | WO2001035990A2 Method for enhancing t cell reactivity toward tumour antigens |
| 05/25/2001 | WO2001035970A1 Viruses for the treatment of cellular proliferative disorders |
| 05/25/2001 | WO2001035968A1 Methods for inducing chondrogenesis and producing de novo cartilage in vitro |
| 05/25/2001 | WO2001035733A1 Method of acquiring immunological tolerance |
| 05/25/2001 | WO2001012235A3 Targeted artificial gene delivery |
| 05/25/2001 | WO2001005942A3 Improved keratinocyte culture and uses thereof |
| 05/25/2001 | WO2000078320A8 Cartilage enhancing food supplements and methods of preparing the same |
| 05/25/2001 | WO2000073338A8 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 05/25/2001 | WO2000070024A3 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses |
| 05/25/2001 | WO2000010582A8 Probiotic, lactic acid-producing bacteria and uses thereof |
| 05/25/2001 | CA2794123A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2720361A1 Viruses for the treatment of cellular proliferative disorders |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392103A1 Human fgf-21 gene and gene expression products |
| 05/25/2001 | CA2391881A1 Transfer compounds, production and use thereof |
| 05/25/2001 | CA2391622A1 Inhibiting gene expression with dsrna |
| 05/25/2001 | CA2390548A1 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | CA2390148A1 Immunotherapy |
| 05/25/2001 | CA2388807A1 Viruses for the treatment of cellular proliferative disorders |
| 05/24/2001 | US20010001817 Implantable device and use therefor |
| 05/24/2001 | US20010001788 Applying an aqueous solution of squid chitosan which exhibits antihistamine activity to an affected portion of the subject suffering from allergic dermatitis |
| 05/24/2001 | US20010001711 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/24/2001 | US20010001662 To treat a behavioral or psychological deficit such as caused by ischema in an animal; intracerebral transplantation; obtaining said cells from human fetus, immortalization of cells |
| 05/24/2001 | CA2290316A1 Novel source of eleutherobin and related antimitotic diterpenes |
| 05/23/2001 | EP1101494A1 Composicion para la estimulacion de la sintesis del pigmento melanico y procedimiento para su obtencion |
| 05/23/2001 | EP1100950A1 Gastrointestinal bacterial antibody factories |
| 05/23/2001 | EP1100946A1 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates |
| 05/23/2001 | EP1100945A2 Latency-active regulatory sequences of herpesviruses and lantency-inactive herpesviruses for gene transfer |
| 05/23/2001 | EP1100944A1 Targeted alphavirus and alphaviral vectors |
| 05/23/2001 | EP1100943A2 Herpesviral vectors for gene delivery |
| 05/23/2001 | EP1100942A2 Herpes virus vectors for dendritic cells |
| 05/23/2001 | EP1100916A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 05/23/2001 | EP1100910A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 05/23/2001 | EP1100895A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/23/2001 | EP1100878A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 05/23/2001 | EP1100875A2 Inhibition of graft versus host disease |
| 05/23/2001 | EP1100874A2 Hematopoietic cell composition for use in transplantation |
| 05/23/2001 | EP1100873A1 Cancer cells from body fluids containing cells, isolation thereof and agents containing the same |
| 05/23/2001 | EP1100871A2 Method for preparing a cartilage cell suspension |
| 05/23/2001 | EP1100870A1 Improvement of cardiac function by mesenchymal stem cell transplantation |
| 05/23/2001 | EP1100830A2 Heterominibodies |
| 05/23/2001 | EP1100826A1 Isoforms of human calcium sensing receptor |
| 05/23/2001 | EP1100817A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 05/23/2001 | EP1100548A2 Genetically engineered cells and tissues |
| 05/23/2001 | EP1100545A1 Regulated expression of recombinant proteins using rna viruses |
| 05/23/2001 | EP1100534A1 Equine system for non-surgical artificial insemination |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/23/2001 | EP1100515A1 $i(EX VIVO) TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 05/23/2001 | EP1100455A1 Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives |
| 05/23/2001 | CN1295857A Plaster |
| 05/23/2001 | CN1295853A Novel medicine for stopping narcotic taking and preparation process thereof |
| 05/23/2001 | CN1295848A Powder medicine for treating born and scald |
| 05/23/2001 | CN1295846A Earthworm compound capsule |
| 05/23/2001 | CN1295845A Traditional Chinese medicine for treating burn and scald and preparation process thereof |
| 05/23/2001 | CN1295842A Shenxian kidney-invigrating extract |
| 05/23/2001 | CN1295841A Adhesive plaster for osteophytosis |
| 05/23/2001 | CN1066196C Process for preparing low-alcohol content pearl Daqu health care liquor |
| 05/23/2001 | CN1066061C Preparation of medicine for treating functional metrorrhagia |
| 05/23/2001 | CN1066060C Hemostatic sterilizing agent |
| 05/23/2001 | CN1066059C Psoriasis plaster |
| 05/23/2001 | CN1066054C Medicine for treating rheumatic diseases |
| 05/23/2001 | CN1066051C Medicine for relieving swelling and transforming stasis and preparation process thereof |
| 05/23/2001 | CN1066050C Tissur regeneration promoting oil for treating trauma and preparation process thereof |
| 05/23/2001 | CN1066048C Spleen tonifying intelligence improving granule for children |
| 05/23/2001 | CN1066043C Traditional Chinese medicinal for treating hyperosteogeny and prolapse of lumbar intervertebral disc |
| 05/23/2001 | CN1066042C Hair regrowth liniment and its preparation method |
| 05/22/2001 | US6235970 CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus |
| 05/22/2001 | US6235969 Cloning pigs using donor nuclei from non-quiescent differentiated cells |
| 05/22/2001 | US6235795 Natural mixture composed of higher primary aliphatic alcohols obtained from bee wax for the treatment of gastric and duodenal ulcers that also present antiinflamatory activity |
| 05/22/2001 | US6235527 Lineage restricted glial precursors from the central nervous system |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/22/2001 | US6235523 Vector having nucleic acid encoding a human papillomavirus-16 e7 antigen lacking the rb protein binding site and operably linked to a cytomegalo virus promoter; vaccines |
| 05/22/2001 | US6235522 Lentiviral vectors |
| 05/22/2001 | US6235497 Viral vector coding rodent transport protein; for treatment of nervous system disorders |
| 05/22/2001 | US6235316 Neocartilage and methods of use |
| 05/17/2001 | WO2001034843A1 Lentiviral vector transduction of hematopoietic stem cells |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034776A1 Hematopoietic differentiation of human embryonic stem cells |
| 05/17/2001 | WO2001034775A1 Mesenchymal stem cells and/or progenitor cells, their isolation and use |
| 05/17/2001 | WO2001034653A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034208A1 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 05/17/2001 | WO2001034206A2 Nucleic acid-containing complex |
| 05/17/2001 | WO2001034168A1 Inhibition of pathogens by bacillus coagulans strains |
| 05/17/2001 | WO2001034167A1 Isolation and expansion of human marrow stromal cells |
| 05/17/2001 | WO2001034166A1 Transplant/implant device and method for its production |
| 05/17/2001 | WO2000049137B1 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |